Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Females With Acne Stay on Spironolactone Longer Than Antibiotics

Publish date:: July 1, 2019

Key clinical point: Female patients with acne may benefit from continuing treatment with spironolactone longer than with oral antibiotics.

Major finding: The mean course duration was significantly longer among female patients treated with spironolactone than among those treated with an oral tetracycline.

Study details: A retrospective, observational study of 11,838 female patients with acne aged 12-40 years.

Disclosures: The study was funded in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Dr. Barbieri is supported by NIAMS and receives partial salary support through a Pfizer Fellowship in Dermatology Patient Oriented Research grant to the Trustees of the University of Pennsylvania.

Citation:

Barbieri JS et al. J Am Acad Dermatol. 2019 Mar 21. doi: 10.1016/j.jaad.2019.03.036.

This Week's Must Reads

Annual WCC visits significantly limit asthma worsening,

Does daily inhaler monitoring improve asthma outcomes in children?,

More severe AD correlates with worse sleep health and attention problems in children,

COVID-19–induced drop in first measles vaccinations sparks resurgence concerns,

Shortcomings identified in study of acne videos on TikTok,

Must Reads in Adolescent Medicine

Shortcomings identified in study of acne videos on TikTok,

Gender surgical outcomes differ following puberty suppression,

Rap music mention of mental health topics more than doubles,

Experts disagree with USPSTF’s take on pediatric blood pressure screening,

Alcohol problems linked to legal performance-enhancement products,